Related references
Note: Only part of the references are listed.Study of SOX combined with intraperitoneal high-dose paclitaxel in gastric cancer with synchronous peritoneal metastasis: A phase II single-arm clinical trial
Li Tu et al.
CANCER MEDICINE (2023)
Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer
Remy Sindayigaya et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)
Sina Vatandoust et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2022)
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
Tomohisa Yamamoto et al.
TRIALS (2022)
Safety and Efficacy of Intraperitoneal Paclitaxel Plus Intravenous Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) for Gastric Cancer with Peritoneal Metastasis
So Hyun Kang et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
Yong Xiang Gwee et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation
Yehong Bin et al.
TRIALS (2022)
Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO
Job P. van Kooten et al.
BMJ OPEN (2022)
Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
Wim Ceelen et al.
EBIOMEDICINE (2022)
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
Daryl K. A. Chia et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Advances in the management of peritoneal malignancies
Vahan Kepenekian et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Intraperitoneal injection of class A TLR9 agonist enhances anti-PD-1 immunotherapy in colorectal peritoneal metastases
Ting Jiang et al.
JCI INSIGHT (2022)
Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer
Yuko Kumagai et al.
IN VIVO (2022)
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer
Mohammad Alyami et al.
EJSO (2021)
A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis
Naminatsu Takahara et al.
INVESTIGATIONAL NEW DRUGS (2021)
Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases
Shin Saito et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
Min Shi et al.
BMC CANCER (2021)
Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT
Liang Zhao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort
Willem J. Koemans et al.
GASTRIC CANCER (2021)
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)
Koen P. Rovers et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis
Manuela Robella et al.
CANCERS (2021)
Primary and metastatic peritoneal surface malignancies
Delia Cortes-Guiral et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
Anouk Rijken et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens
Andreas Brandl et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis
Suguru Yamada et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects
Paul H. Sugarbaker
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Intraperitoneal Paclitaxel Combined with S-1 Plus Oxaliplatin for Advanced Gastric Cancer with Peritoneal Metastasis: a Phase I Study
Dong-Wook Kim et al.
JOURNAL OF GASTRIC CANCER (2021)
PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases
Guowei Kim et al.
CLINICAL CANCER RESEARCH (2021)
Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis
Daisuke Kobayashi et al.
ONCOLOGY (2020)
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowl cancer
Ines Gockel et al.
TUMORI JOURNAL (2020)
Phase I/IIstudy of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis
S. Yamada et al.
BRITISH JOURNAL OF SURGERY (2020)
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial
Michele De Simone et al.
BIOMEDICINES (2020)
A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers
Frederic Dumont et al.
EUROPEAN JOURNAL OF CANCER (2020)
Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
Zhongyin Yang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2020)
Efficacy of intraperitoneally administered paclitaxel for colorectal cancer with peritoneal metastases
Koji Murono et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Multicenter Retrospective Analysis of Intraperitoneal Paclitaxel and Systemic Chemotherapy for Advanced Gastric Cancer with Peritoneal Metastasis
Dong-Wook Kim et al.
JOURNAL OF GASTRIC CANCER (2020)
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: A meta-analysis
Claudia Marchetti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
Mohammad Alyami et al.
LANCET ONCOLOGY (2019)
Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study
Nadine L. de Boer et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial
Koji Murono et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
Mihaela C. Cristea et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer
Sarah E. Taylor et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial
Nadine Leonie de Boer et al.
BMJ OPEN (2019)
Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study
Florian Struller et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review
Paul L. Feingold et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2018)
Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review
Juliette O. A. M. van Baal et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2018)
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Femke M. de Man et al.
CLINICAL PHARMACOKINETICS (2018)
Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices
Smrithi Padmakumar et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
Hironori Ishigami et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer
Philipp Horvath et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study
Florian Kurtz et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)
Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis
Martin Graversen et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study
Ines Gockel et al.
JOURNAL OF GASTRIC CANCER (2018)
Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
Daisuke Kobayashi et al.
GASTRIC CANCER (2017)
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
Hyungwoo Cho et al.
GASTRIC CANCER (2017)
Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma
Tanja Khosrawipour et al.
PLOS ONE (2017)
Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis
Mohammad Alyami et al.
EJSO (2017)
Malignant peritoneal mesothelioma: a review
Joseph Kim et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis
Sohei Satoi et al.
ANNALS OF SURGERY (2017)
Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral Chemotherapy
Maria Ornella Nicoletto et al.
ANTICANCER RESEARCH (2016)
Safety and Effectiveness of Percutaneously Inserted Peritoneal Ports Compared to Surgically Inserted Ports in a Retrospective Study of 87 Patients with Ovarian Carcinoma over a 10-Year Period
Joel Woodley-Cook et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites
Naminatsu Takahara et al.
INVESTIGATIONAL NEW DRUGS (2016)
Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model
Veria Khosrawipour et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
Jan Franko et al.
LANCET ONCOLOGY (2016)
Molecular mechanisms of peritoneal dissemination in gastric cancer
Mitsuro Kanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
A combined modality therapeutic approach to metastatic anal squamous cell carcinoma with systemic chemotherapy and local therapy to sites of disease: case report and review of literature
Rosana Gnanajothy et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer
Sarah E. Taylor et al.
GYNECOLOGIC ONCOLOGY (2015)
Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study
Clemens B. Tempfer et al.
GYNECOLOGIC ONCOLOGY (2015)
Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer
Josep Tabernero et al.
ONCOLOGIST (2015)
Clinical Significance of Cytological Status of Peritoneal Lavage Fluid During Intraperitoneal Chemotherapy for Gastric Cancer with Overt Peritoneal Dissemination
Shigenobu Emoto et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
Irene Thomassen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Intraperitoneal chemotherapy: Rationale, applications, and limitations
Osama M. Al-Quteimat et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2014)
A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis
Hironori Yamaguchi et al.
CANCER (2013)
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis
S. Fushida et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics
Csilla Hasovits et al.
CLINICAL PHARMACOKINETICS (2012)
Complications and Management of an Implanted Intraperitoneal Access Port System for Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastasis
Shigenobu Emoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?
Paul H. Sugarbaker
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
Lana Bijelic et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
Rationale for Heating Oxaliplatin for the Intraperitoneal Treatment of Peritoneal Carcinomatosis A Study of the Effect of Heat on Intraperitoneal Oxaliplatin Using a Murine Model
Nelson Piche et al.
ANNALS OF SURGERY (2011)
Systematic review of intraperitoneal chemotherapy for gastric cancer
G. Matharu et al.
BRITISH JOURNAL OF SURGERY (2011)
Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding
Moon Ki Choi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Treatment of Gastric Cancer With Peritoneal Carcinomatosis by Cytoreductive Surgery and HIPEC: A Systematic Review of Survival, Mortality, and Morbidity
Richdeep S. Gill et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
The Levels of Evidence and Their Role in Evidence-Based Medicine
Patricia B. Burns et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma
Chigusa Morizane et al.
PANCREAS (2011)
Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer : phase I study
Nobuhiro Kurita et al.
JOURNAL OF MEDICAL INVESTIGATION (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
H. Ishigami et al.
ANNALS OF ONCOLOGY (2010)
Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration
Byung-Jin Ahn et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer
Joji Kitayama et al.
ONCOLOGY (2010)
Phase I Study of Biweekly Intravenous Paclitaxel plus Intraperitoneal Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Metastasis
Hironori Ishigami et al.
ONCOLOGY (2010)
A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy
Tristan D. Yan et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin
Kurt Van der Speeten et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model
Danielle D. Jandial et al.
GYNECOLOGIC ONCOLOGY (2009)
Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer
Hironori Ishigami et al.
ONCOLOGY (2009)
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
L. M. Hess et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity
Robert J. Morgan et al.
CLINICAL CANCER RESEARCH (2007)
Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: From laboratory bench to bedside
Eelco de Bree et al.
CANCER TREATMENT REVIEWS (2006)
Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination
E. de Bree et al.
EJSO (2006)
Peritoneal carcinomatosis of colorectal origin - Incidence and current treatment strategies
MJ Koppe et al.
ANNALS OF SURGERY (2006)
The transport barrier in intraperitoneal therapy
MF Flessner
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: Results of a phase II trial
AK Sood et al.
CLINICAL CANCER RESEARCH (2004)
A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery
F Mohamed et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer
E de Bree et al.
ANTI-CANCER DRUGS (2003)
Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma
DT Le et al.
CANCER INVESTIGATION (2003)
Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer
LS Hofstra et al.
GYNECOLOGIC ONCOLOGY (2002)
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
D Elias et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
